Contract 36F79721D0188
Geri-Care Pharmaceuticals Corp. · Department Of Veterans Affairs · September 10, 2021
Geri-Care Pharmaceuticals Corp. was awarded a federal contract by Department Of Veterans Affairs on September 10, 2021 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 8, 2026. If all options are exercised, the contract could reach $225,000.
Contract details
- PIID
- 36F79721D0188
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 10, 2021
- Latest action
- January 8, 2026
Description
PRODUCT ADDITION
Modification timeline
-
January 8, 2026Mod P00024 · Supplemental Agreement For Work Within Scope$0
-
August 25, 2025Mod P00023 · Supplemental Agreement For Work Within ScopeNDC CHANGES AND PRODUCT DELETIONS$0
-
August 20, 2024Mod P00017 · Supplemental Agreement For Work Within ScopeFSS$0
-
July 3, 2024Mod P00016 · Supplemental Agreement For Work Within ScopeFSS$0
-
September 10, 2021Mod P00001 · Supplemental Agreement For Work Within ScopePRODUCT ADDITIONS$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79721D0188?
Contract 36F79721D0188 is a federal contract awarded to Geri-Care Pharmaceuticals Corp. by Department Of Veterans Affairs on September 10, 2021 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 4 times since the base award.
Who won contract 36F79721D0188?
Geri-Care Pharmaceuticals Corp. won contract 36F79721D0188 from Department Of Veterans Affairs.
How much is contract 36F79721D0188 worth?
Contract 36F79721D0188 has obligated $0 to date but carries a potential ceiling of $225,000 if fully funded and all options are exercised.